Convexity Labs

RXO

Convexity Analyst · RXO
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

RXO, Inc. (RXO) Analyst Note

Date: 2026-06-20 Current Price: $25.39

1. Structural Readiness

  • Conservative Entry: Not yet defined (awaiting breakout confirmation)
  • Aggressive/Pre-Breakout Entry: N/A (Current price is $25.39; no specific breakout level defined in current context)
  • Breakout Level: Not yet defined
  • Extension: Not Applicable
  • ATR Current: 6.2% (Very High)

2. Thesis Layer

As of 2026-06-20, RXO is classified as a TACTICAL, setup-led name. There is no named secular thesis attached to this specific setup at this date. The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals provided in the evidence base. No macro or secular themes should be invented to bolster conviction; the focus remains on the structural setup and the company's operational execution.

3. Business Overview

RXO, Inc. operates as a brokered transportation platform defined by a cutting-edge technology and asset-light business model. The company's core business is truck brokerage, complemented by asset-light managed transportation and last-mile services.

  • Operational Model: RXO places freight for shippers with qualified independent carriers using its proprietary technology. It serves as the largest provider of outsourced last-mile transportation for heavy goods in the United States, positioned within 125 miles of the vast majority of the U.S. population.
  • Customer Base: The company serves a diversified mix of verticals including retail, e-commerce, food and beverage, industrial, and automotive. Approximately half of the Fortune 500 entrusts RXO with their freight.
  • Recent Performance (Q1 2026):
  • Revenue: $1,425 million (down $8 million year-over-year from $1,433 million in Q1 2025).
  • Pipeline Growth: The company was awarded over $100 million in freight under management in Q1, with the late-stage sales pipeline increasing by more than $200 million.
  • New Solutions: A new solution launched in February 2026 has already secured a sales pipeline of over $70 million and $20 million in wins.
  • Market Dynamics: Capacity continues to exit the market due to regulatory changes and enforcement, a trend management views as structural. This has led to a 500 basis point sequential increase in spot mix, driving strong gross profit per load improvement.
  • Financial Structure: On February 5, 2026, RXO entered into a $450 million asset-based revolving credit facility (ABL Facility) to repay and terminate its previous revolving credit agreement.
  • Customer Concentration: In 2025, the top 20 customers accounted for 37% of revenue, with the single largest customer representing 11.4% ($653 million) of total revenue.

4. Archetype and Conviction

  • Archetype: Growth Leader.
  • Rationale: The company demonstrates strong top-line momentum in terms of pipeline growth ($200M+ increase) and new solution adoption ($70M pipeline in <6 months). Management expects full-year 2026 contract rates to increase by high single digits, an upgrade from prior low-to-mid-single-digit expectations. The business model is asset-light, allowing for rapid scaling without heavy capex, and the company is leveraging structural capacity exits in the industry to improve margins (spot mix up 500 bps).
  • Conviction Stack:
  • Thesis Strength: Moderate. The setup is tactical, not secular. The business fundamentals are strong (pipeline growth, margin expansion), but the lack of a named macro thesis limits the "secular" conviction weight.
  • Evidence Quality: High. The evidence base is robust, citing specific earnings transcripts and SEC filings from May 2026 and February 2026.
  • Rerating Potential: Dependent on the successful execution of the "high single-digit" rate growth and the ability to convert the $200M+ pipeline into booked revenue. The structural capacity exit in the industry provides a favorable tailwind for pricing power.

5. Invalidations, Strengths, and Gaps

  • What Would Strengthen: A confirmed breakout above the current consolidation range (firing the coil) would confirm the setup. Continued expansion of the spot mix and successful integration of the new February solution (converting the $20M wins to recurring revenue) would strengthen the fundamental case.
  • Gaps in Evidence:
  • Valuation Metrics: The evidence base lacks specific P/E, EV/EBITDA, or P/S ratios as of June 2026. Without these, relative valuation context is missing.
  • Profitability Details: While adjusted EBITDA guidance for Q2 ($27M-$37M) is provided, specific net income or GAAP earnings per share (EPS) figures for Q1 2026 are not detailed in the provided text, limiting a full profitability assessment.
  • Capex/Debt Service: While the new $450M ABL facility is noted, specific debt service costs or capex plans for 2026 are not explicitly quantified in the evidence.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 2026 late-stage sales pipeline increased by >$200M; Management raised full-year 2026 contract rate guidance to high single digits; Spot mix increased 500 bps sequentially driving gross profit per load improvement. Key risks: Very high ATR (6.2%) indicates elevated volatility and potential for sharp reversals; Revenue declined 0.5% YoY in Q1 despite pipeline growth; Customer concentration risk with top customer at 11.4% of revenue. Sizing hint: Position size should be reduced relative to the ATR to account for the "very high" volatility bucket; do not size as a confirmed breakout. Expected path: Management expects contract rates to grow high single digits in 2026; structural capacity exits should support pricing power; the forming coil suggests a potential breakout if the pipeline converts to revenue. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).

Loading chart...
Exhibit 1: RXO daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for RXO.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for RXO.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: